Shandong Sinobioway Biomedicine Co (SZSE:002581) ROCE % : -2.17% (As of Sep. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Shandong Sinobioway Biomedicine Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Shandong Sinobioway Biomedicine Co's annualized ROCE % for the quarter that ended in Sep. 2024 was -2.17%.

Shandong Sinobioway Biomedicine Co ROCE % Historical Data

The historical data trend for Shandong Sinobioway Biomedicine Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Sinobioway Biomedicine Co ROCE % Chart

Shandong Sinobioway Biomedicine Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

3.38

-6.49

11.99

0.87

-12.94

Shandong Sinobioway Biomedicine Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
ROCE %	Get a 7-Day Free Trial															-5.20	-38.17	-4.12	0.06	-2.17

Shandong Sinobioway Biomedicine Co ROCE % Calculation

Shandong Sinobioway Biomedicine Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-304.614	/	( ( (2870.251 - 364.28)	+	(2337.138 - 133.608) )	/ 2 )
	=	-304.614	/	( (2505.971	+	2203.53)	/ 2 )
	=	-304.614	/	2354.7505
	=	-12.94 %

Shandong Sinobioway Biomedicine Co's ROCE % of for the quarter that ended in Sep. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Sep. 2024 )		(Q: Jun. 2024 )		(Q: Sep. 2024 )
	=	-47.96	/	( ( (2269.414 - 86.243)	+	(2295.888 - 64.554) )	/ 2 )
	=	-47.96	/	( ( 2183.171	+	2231.334 )	/ 2 )
	=	-47.96	/	2207.2525
	=	-2.17 %

(1) Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

Shandong Sinobioway Biomedicine Co (SZSE:002581) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Shandong Sinobioway Biomedicine Co ROCE % Related Terms

Thank you for viewing the detailed overview of Shandong Sinobioway Biomedicine Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Shandong Sinobioway Biomedicine Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shandong Sinobioway Biomedicine Co Ltd (SZSE:002581) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No.18, Chaoyang Road, Zhangdian District, Zibo City, Shandong, CHN, 255068

Website

http://www.wanchang.com

Shandong Sinobioway Biomedicine Co Ltd is engaged in the research, development, manufacturing and marketing of trimethyl orthoformate and triethyl orthoformate.

Executives

He Xun	Executives
Yang Xiao Min	Director
Yu Tong Jie	Executives
Yan Li	Director

Shandong Sinobioway Biomedicine Co Headlines

No Headlines